ABOUT DIAMYD MEDICAL
ABOUT DIAMYD MEDICAL
CEO Comments
The Diamyd Story
Board & Management
Contact Us
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
Diamyd US Operations
Partnering
DIABETES
DIABETES
Type 1
LADA
Type 2
Complications
Diamyd
®
Products
PRODUCTS & PIPELINE
PRODUCTS & PIPELINE
Diamyd
®
Products
Diamyd
®
for type 1
Diamyd
®
for LADA
NTDDS products
NP2
NG2
NC3
Partnering
SCIENCE & TECHNOLOGY
SCIENCE & TECHNOLOGY
GAD platform
NTDDS platform
Clinical development
Scientific publications
Scientific advisory board
CLINICAL TRIALS
CLINICAL TRIALS
Phase III Trials - USA
Phase III Trials - Europe
INVESTOR RELATIONS
INVESTOR RELATIONS
Press Releases
Financial Reports
IR Calendar
Owners
Share Trading
Board & Management
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
PRESS ROOM
PRESS ROOM
Press Releases
News & Mediawatch
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Home
»
Press Room
»
Media Contact
Media Contact
For media contact, press material and pictures, please contact Andreas Ericsson on +46-8-6610026 or e-mail:
jBD2mY4.zeSHsn9h@BRKiel.com
Press Room
Press Releases
News & Mediawatch
Webcasts/Podcasts
Newsletter Subscription
Media Contact